Assuntos
Teste de Ácido Nucleico para COVID-19/normas , COVID-19/diagnóstico , Instituição de Longa Permanência para Idosos , Nasofaringe/virologia , Casas de Saúde , Adulto , Idoso de 80 Anos ou mais , COVID-19/transmissão , Reações Falso-Negativas , Feminino , França/epidemiologia , Humanos , Masculino , Programas de Rastreamento/métodos , Programas de Rastreamento/organização & administração , Programas de Rastreamento/normas , Pessoa de Meia-Idade , Recursos Humanos de Enfermagem Hospitalar/estatística & dados numéricos , Pandemias , Avaliação de Programas e Projetos de Saúde , RNA Viral/análise , RNA Viral/isolamento & purificação , Estudos Retrospectivos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , SARS-CoV-2/genética , SARS-CoV-2/isolamento & purificaçãoRESUMO
BACKGROUND: The established relationship between vision impairment and depression is limited by the examination of depression only as a unidimensional construct. The present study explores the vision-depression relationship using a dimensional approach. METHODS: 9036 participants aged 65 years and above enrolled in the Three-City study were included. Relationships between baseline near Vision Impairment (VI) or self-reported distance Visual Function (VF) loss with trajectory of four dimensions of depression - depressed affect, positive affect, somatic symptoms and interpersonal problems - over 12 years were examined using mixed-effects models. Depression dimensions were determined using the four-factor structure of the Centre for Epidemiology Studies-Depression Scale (CESD). RESULTS: In the fully adjustment models, mild near VI predicted poorer depressed affect (bâ¯=â¯0.04, pâ¯=â¯.002) and positive affect (bâ¯=â¯-0.06, pâ¯<â¯0.001) over time, with evidence of longer term adjustment. Distance VF loss was associated with poorer depressed affect (bâ¯=â¯0.27, pâ¯≤â¯.001), positive affect (bâ¯=â¯-0.15, pâ¯=â¯.002), and somatic symptoms (bâ¯=â¯0.18, pâ¯≤â¯.001) at baseline, although only the association with depressed affect was significant longitudinally (bâ¯=â¯0.01, pâ¯=â¯.001). Neither near VI nor distance VF loss was associated with interpersonal problems. LIMITATIONS: This paper uses a well-supported model of depression dimensions, however, there remains no definite depression dimension model. Distance VF loss was self-reported, which can be influenced by depression symptoms. CONCLUSIONS: Vision impairment in older adults is primarily associated with affective dimensions of depression. A reduction in social connectedness and ability to engage in pleasurable activities may underlie the depression-vision relationship. Older adults with vision impairment may benefit from targeted treatment of affective symptoms, and pleasant event scheduling.
Assuntos
Depressão/epidemiologia , Índice de Gravidade de Doença , Transtornos da Visão/epidemiologia , Acuidade Visual , Idoso , Idoso de 80 Anos ou mais , Causalidade , Transtorno Depressivo/epidemiologia , Feminino , Humanos , Incidência , Masculino , Fatores de Risco , Autorrelato , Transtornos da Visão/psicologiaRESUMO
OBJECTIVE: the aim of this study was to examine the bidirectional association of vision loss (VL) and hearing loss (HL) with anxiety over a 12-year period. DESIGN: this was a prospective population-based study. SETTING: community-dwelling French adults. PARTICIPANTS: the study included 3,928 adults aged 65 and above from the Three-City study. METHODS: the relationships of VL, as assessed by near visual acuity and self-reported HL to a diagnosis of generalised anxiety disorder (GAD) were assessed over 12 years. A further objective was to explore whether sensory loss has a differential relationship with GAD than with anxiety symptoms, assessed by the Spielberger's State-Trait Anxiety Inventory. RESULTS: at baseline, HL [odds ratio (OR) = 1.41, 95% confidence interval (CI) 1.02-1.96, P = 0.04], but not mild or moderate to severe VL, was associated with self-reported anxiety symptoms (OR = 1.07 95% CI 0.63-1.83, P = 0.80; OR = 0.66 95% CI 0.12-2.22, P = 0.50, respectively). Neither vision nor HL was significantly associated with incident GAD. Baseline GAD was related to increased risk of incident HL (OR = 1.17, 95% CI 1.07-1.28, P < 0.001), but not mild or moderate to severe vision loss (OR = 1.01, 95% CI 0.96-1.06, P = 0.81; OR = 0.97, 95% CI 0.89-1.05, P = 0.45, respectively). CONCLUSIONS: increased anxiety symptoms were observed in older adults with HL, whereas we found no evidence for an association between VL and anxiety. Anxiety was prospectively associated with increased risk of reporting HL. Improved detection of anxiety in older adults with HL may improve quality of life.